<DOC>
	<DOC>NCT01395550</DOC>
	<brief_summary>AstraZeneca was interested in knowing how Cardiologists and Physicians treat patients who have suffered a cardiovascular event.</brief_summary>
	<brief_title>Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event</brief_title>
	<detailed_description />
	<criteria>All patients who has experienced cardiovascular events Patients with no cardiovascular events.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>